{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:15:43Z","timestamp":1794968143305,"version":"4.9.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaad.2023.12.070","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T01:40:03Z","timestamp":1707270003000},"page":"1170-1181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation"],"prefix":"10.1016","volume":"90","author":[{"given":"Vipawee S.","family":"Chat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph T.","family":"Ellebrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Gondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Cordoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemal R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina C.","family":"Duffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Kircik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Michael Lewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Orbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya M.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Ritchlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan L.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby S.","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jaad.2023.12.070_bib1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jid.2018.01.039","article-title":"Risk of serious infection, opportunistic infection, and herpes zoster among patients with psoriasis in the United Kingdom","volume":"138","author":"Takeshita","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jid.2017.07.841","article-title":"Objective measures of psoriasis severity predict mortality: a prospective population-based cohort study","volume":"138","author":"Noe","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jid.2018.09.012","article-title":"Influenza vaccination rates in adults with psoriasis compared to adults with other chronic diseases","volume":"139","author":"Noe","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2013.06.046","article-title":"From the medical board of the National Psoriasis Foundation: vaccination in adult patients on systemic therapy for psoriasis","volume":"69","author":"Wine-Lee","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.070_bib72","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/jix653","article-title":"Varicella-zoster virus DNA in blood after administration of herpes zoster vaccine","volume":"217","author":"Levin","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2023.12.070_bib73","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM196007282630408","article-title":"Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine","volume":"263","author":"Katz","year":"1960","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.070_bib74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/infdis\/175.3.524","article-title":"Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies","volume":"175","author":"van Binnendijk","year":"1997","journal-title":"J Infect Dis"},{"issue":"8229","key":"10.1016\/j.jaad.2023.12.070_bib75","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(81)92243-1","article-title":"Rubella viraemia and antibody responses after rubella vaccination and reimmunization","volume":"1","author":"Balfour","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2023.12.070_bib76","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1056\/NEJM196507222730404","article-title":"Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus","volume":"273","author":"Wheelock","year":"1965","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.070_bib78","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/381101","article-title":"Lack of vaccinia viremia after Smallpox vaccination","volume":"38","author":"Cummings","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jaad.2020.09.001","article-title":"National Psoriasis Foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: version 1","volume":"83","author":"Gelfand","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.070_bib6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaad.2020.12.058","article-title":"National Psoriasis Foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments","volume":"84","author":"Gelfand","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2023.12.070_bib9","series-title":"The RAND\/UCLA appropriateness method user's manual","author":"Fitch","year":"2001"},{"key":"10.1016\/j.jaad.2023.12.070_bib10","series-title":"SOTYKTU [package insert]","year":"2022"},{"issue":"9","key":"10.1016\/j.jaad.2023.12.070_bib11","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell Signal"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.070_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.61.7.623","article-title":"Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis","volume":"61","author":"Elkayam","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jaad.2023.12.070_bib13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/ard.2003.013201","article-title":"Hepatitis B vaccination in children with juvenile idiopathic arthritis","volume":"63","author":"Kasap\u00e7opur","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib14","doi-asserted-by":"crossref","first-page":"O41","DOI":"10.1186\/1546-0096-9-S1-O41","article-title":"Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases","volume":"9","author":"Heijstek","year":"2011","journal-title":"Pediatric Rheumatology"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.vaccine.2016.12.068","article-title":"Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine","volume":"35","author":"Kapetanovic","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jaad.2023.12.070_bib16","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/art.30580","article-title":"Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors","volume":"63","author":"Kapetanovic","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13075-015-0662-x","article-title":"Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus","volume":"17","author":"Migita","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3899\/jrheum.170710","article-title":"A systematic review and metaanalysis of antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis","volume":"45","author":"Subesinghe","year":"2018","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.070_bib19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/acr.22246","article-title":"Effect of methotrexate, anti-tumor necrosis factor \u03b1, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"66","author":"Hua","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib20","first-page":"898","article-title":"Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.070_bib22","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jaad.2023.12.070_bib23","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.7326\/M20-6928","article-title":"The safety and immunologic effectiveness of the live varicella zoster vaccine in patients receiving tumor necrosis factor inhibitor therapy: a randomized controlled trial","volume":"174","author":"Curtis","year":"2021","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa126","article-title":"Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy\u2014a prospective multi-centre pilot study1","volume":"27","author":"B\u00fchler","year":"2020","journal-title":"J Travel Med"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.070_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0162-3109(85)90044-X","article-title":"Effect of methotrexate on the immune response in children with acute lymphatic leukaemia","volume":"9","author":"O'Meara","year":"1985","journal-title":"Immunopharmacology"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/tid.12140","article-title":"Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors","volume":"15","author":"Azevedo","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.070_bib28","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/00007890-199811270-00014","article-title":"Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation","volume":"66","author":"Dengler","year":"1998","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.070_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007890-198610000-00009","article-title":"Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine","volume":"42","author":"Versluis","year":"1986","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.01.00215201","article-title":"The humoral immune response to influenza vaccination in lung transplant patients","volume":"18","author":"Mazzone","year":"2001","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.jaad.2023.12.070_bib31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/TP.0b013e3181f5d878","article-title":"Immunity to pneumococcal antigens in kidney transplant recipients","volume":"90","author":"Lindemann","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/TP.0b013e318250fc8c","article-title":"Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients","volume":"94","author":"Lindemann","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib33","first-page":"168","article-title":"Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation","volume":"32","author":"Duca","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00915009","article-title":"The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans","volume":"5","author":"Palestine","year":"1985","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.070_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/annrheumdis-2014-207191","article-title":"The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis","volume":"75","author":"Winthrop","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib39","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jaad.2017.09.076","article-title":"T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment","volume":"78","author":"Winthrop","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.070_bib37","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/art.40187","article-title":"The safety and immunogenicity of live zoster vaccination in patients with rheumatoid arthritis before starting tofacitinib: a randomized phase II trial","volume":"69","author":"Winthrop","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.070_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/annrheumdis-2019-216566","article-title":"Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib","volume":"79","author":"Winthrop","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.070_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.24010","article-title":"Live zoster vaccine in patients with rheumatoid arthritis treated with tofacitinib with or without methotrexate, or adalimumab with methotrexate: a post Hoc analysis of data from a phase IIIb\/IV randomized study","volume":"72","author":"Calabrese","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib41","first-page":"181","article-title":"Immunogenicity and safety of vaccination against seasonal 2012 influenza virus among patients with psoriatic arthritis and psoriasis","volume":"33","author":"Polachek","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/cei.12292","article-title":"Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals","volume":"177","author":"Milanetti","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/s10165-007-0632-5","article-title":"Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis","volume":"17","author":"Kubota","year":"2007","journal-title":"Modern Rheumatology"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib44","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/ard.2005.036434","article-title":"Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers","volume":"65","author":"Fomin","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.070_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.070_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","article-title":"The effect of anti-tumour necrosis factor \u03b1 treatment on the antibody response to influenza vaccination","volume":"67","author":"Gelinck","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib48","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","article-title":"The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Elkayam","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.070_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3899\/jrheum.130945","article-title":"Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial","volume":"41","author":"Kivitz","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.070_bib51","first-page":"1356","article-title":"Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept","volume":"31","author":"Mease","year":"2004","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jbspin.2015.10.017","article-title":"Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept","volume":"83","author":"R\u00e1k\u00f3czi","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib53","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.070_bib54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/21645515.2019.1574151","article-title":"High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study","volume":"15","author":"Haykir Solay","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jaad.2023.12.070_bib56","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3949\/ccjm.87a.20056","article-title":"The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults","volume":"87","author":"Day","year":"2020","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib57","first-page":"677","article-title":"Effects of ustekinumab administration on primate\/human antigen-recall and humoral immune response functions","volume":"9","author":"Brodmerkel","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.070_bib58","first-page":"1122","article-title":"Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use","volume":"12","author":"Brodmerkel","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.070_bib59","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/vaccines8030455","article-title":"High immunogenicity to influenza vaccination in crohn's disease patients treated with ustekinumab","volume":"8","author":"Doornekamp","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.070_bib60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.vaccine.2019.10.081","article-title":"Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab","volume":"38","author":"Furer","year":"2020","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.070_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001018","article-title":"Secukinumab does not impair the immunogenic response to the influenza vaccine in patients","volume":"5","author":"Richi","year":"2019","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.070_bib62","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1128\/CVI.00386-12","article-title":"Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study","volume":"19","author":"Chioato","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.070_bib63","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40259-017-0249-y","article-title":"Response to tetanus and pneumococcal vaccination following administration of ixekizumab in healthy participants","volume":"31","author":"Gomez","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaad.2023.12.070_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12891-016-1082-z","article-title":"Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept","volume":"17","author":"Alten","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"42","key":"10.1016\/j.jaad.2023.12.070_bib65","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1016\/j.vaccine.2013.07.086","article-title":"Effect of abatacept on immunogenicity of vaccines in individuals with type 1 diabetes","volume":"31","author":"Weinberg","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2023.12.070_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s13075-015-0863-3","article-title":"Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients","volume":"17","author":"Migita","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.070_bib67","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar4358","article-title":"Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis","volume":"15","author":"Crnkic Kapetanovic","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2023.12.070_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1034\/j.1600-0625.11.s.1.4.x","article-title":"Mechanisms underlying UV-induced immune suppression: implications for sunscreen design","volume":"11","author":"Ullrich","year":"2002","journal-title":"Exp Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.12.070_bib69","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.jaad.2023.12.070_bib70","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.070_bib71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaad.2019.03.017","article-title":"A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: from the medical board of the National Psoriasis Foundation","volume":"81","author":"Baumrin","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:51:57Z","timestamp":1732611117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0190962224002433"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.12.070","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.12.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}